MedPath

NXC-736

Generic Name
NXC-736

Safety and Efficacy of Oral NXC-736 in Adult Participants with Moderate and Severe Alopecia Areata

Phase 2
Recruiting
Conditions
Alopecia Areata
Interventions
Drug: Placebo
First Posted Date
2023-10-27
Last Posted Date
2024-12-17
Lead Sponsor
NEXTGEN Bioscience
Target Recruit Count
96
Registration Number
NCT06104839
Locations
🇰🇷

Seoul National University Hospital., Seoul, Korea, Republic of

🇰🇷

Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of

A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2021-10-15
Last Posted Date
2023-02-08
Lead Sponsor
NEXTGEN Bioscience
Target Recruit Count
72
Registration Number
NCT05079425
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath